Your chances of a migraine increase with hotter temperatures
Research by Dr. Vincent Martin is featured in national and international media
A change in weather is one of the most common trigger factors for migraine. Hotter temperatures increase the chance of a migraine attack, according to research led by Vincent Martin, MD, director of the Headache and Facial Pain Center at UC’s Gardner Neuroscience Institute.
Martin, also a professor in the UC College of Medicine, spoke with Cincinnati’s Fox 19 News about his latest study findings which looked at use of Fremanezumab and whether it could prevent headaches caused by temperature increases. Produced by Teva Pharmaceuticals USA, Fremanezumab is sold under the brand name AJOVY®, administered by injection under the skin to treat migraines.
A research team led by Martin cross-referenced 71,030 daily diary records of 660 migraine patients with regional weather data and found that for every temperature increase of 10 degrees Fahrenheit daily, there was a 6% increase in occurrence of any headache. However, during the time periods of Fremanezumab treatment the association completely disappeared.
Record high temperatures across much of the Midwest and Northeast regions of the country has increased dialogue about health ailments associated with the heat. Martin’s findings were reported on more than 200 media outlets including CBS News, The Atlanta Journal Constitution, The Miami Herald and internationally in publications such as Greece’s Tempo 24, Argentina’s Infobae, Italy’s Agenzia Italia, Mexico’s El Cuarto Poder , Venezuela’s Noticias Venevision and Indonesia’s Suara Merdeka.
Read about the research findings from Vincent Martin, MD, online.
Learn more about migraines and hotter temperatures on CBS News
Featured top image is courtesy of Istock.
Related Stories
An expert pieced together this Roman document like a puzzle
September 1, 2026
National media highlighted a new project by UC Classics Assistant Professor Matthijs Wibier to piece together and translate an ancient Roman text from fragments buried in the desert for more than 1,600 years.
Cancer Center physician receives $150,000 New Investigator Research Grant to study treatment-resistant leukemia
September 1, 2026
The University of Cincinnati Cancer Center’s Sarah Skuli, MD, PhD, received a two‑year, $150,000 Leukemia Research Foundation New Investigator Grant to study TP53‑mutated leukemia, a treatment‑resistant subtype with very poor outcomes.
Her book drive is changing literacy in Cincinnati
August 31, 2026
WCPO highlights a nonprofit dedicated to childhood literacy that has offers co-op positions to UC students.